Kite, Pfizer enter clinical trial collaboration
Gilead Sciences Inc.'s Kite Pharma Inc. is teaming up with Pfizer Inc. in a trial collaboration to study the safety and efficacy of Kite's Yescarta (axicabtagene ciloleucel) in combination with Pfizer's utomilumab (PF05082566) for treating patients with refractory large B-cell lymphoma.
- Gene Therapy, Cell Therapy
- Trial Collaborations
- R&D (No Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com